Sarcomatoid neoplasms of the lung and pleura

Archives of Pathology and Laboratory Medicine

Volumn 134, Issue 11, 2010, Pages 1645-1658

  Travis, William D ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGE; ARTICLE; CARCINOSARCOMA; HUMAN; LUNG TUMOR; PATHOLOGY; PLEURA TUMOR; PROGNOSIS; SARCOMA;

AGE FACTORS; CARCINOSARCOMA; HUMANS; LUNG NEOPLASMS; PLEURAL NEOPLASMS; PROGNOSIS; SARCOMA;

EID: 78349276173     PISSN: 00039985     EISSN: 15432165     Source Type: Journal    
DOI: None     Document Type: Article

References (122)

1. Travis WD, Travis LB, Devesa SS. Lung cancer [erratum in Cancer. 1995;15;75(12):2979]. Cancer. 1995;75 (1 suppl):191-202.
2. Travis WD, Brambilla E, Müller-Hermelink HK, Harris CC, eds. Pathology and Genetics of Tumours of the Lung, Pleura, Thymus and Heart. Lyon, France: IARC Press; 2004. World Health Organization Classification of Tumours; vol 10.
3. Fishback NF, Travis WD, Moran CA, Guinee DG Jr, McCarthy WF, Koss MN. Pleomorphic (spindle/giant cell) carcinoma of the lung: a clinicopathologic correlation of 78 cases. Cancer. 1994;73(12):2936-2945.
4. Pelosi G, Sonzogni A, De Pas T, et al. Pulmonary sarcomatoid carcinomas: a practical overview. Int J Surg Pathol. 2010:18(2):103-120.
5. Kenmotsu H, Ishii G, Nagai K, et al. Pleomorphic carcinoma of the lung expressing podoplanin and calretinin. Pathol Int. 2008;58(12):771-774.
6. Mochizuki T, Ishii G, Nagai K, et al. Pleomorphic carcinoma of the lung: clinicopathologic characteristics of 70 cases. Am J Surg Pathol. 2008;32(11): 1727-1735.
7. Rossi G, Cavazza A, Sturm N, et al. Pulmonary carcinomas with pleomorphic, sarcomatoid, or sarcomatous elements: a clinicopathologic and immunohistochemical study of 75 cases. Am J Surg Pathol. 2003;27(3):311-324.
8. Francis D, Jacobsen M. Pulmonary blastoma. Curr Top Pathol. 1983;73: 265-294.
9. Jacobsen M, Francis D. Pulmonary blastoma: a clinico-pathological study of eleven cases. Acta Pathol Microbiol Scand A. 1980;88(3):151-160.
10. Adluri RK, Boddu SR, Martin-Ucar A, Duffy JP, Beggs FD, Morgan WE. Pulmonary blastoma-a rare tumor with variable presentation. Eur J Cardiothorac Surg. 2006;29(2):236-239.
11. Robert J, Pache JC, Seium Y, de Perrot M, Spiliopoulos A. Pulmonary blastoma: Report of five cases and identification of clinical features suggestive of the disease. Eur J Cardiothorac Surg. 2002;22(5):708-711.
12. Zaidi A, Zamvar V, Macbeth F, Gibbs AR, Kulatilake N, Butchart EG. Pulmonary blastoma: medium-term results from a regional center. Ann Thorac Surg. 2002;73(5):1572-1575.
13. Koss MN. Pulmonary blastomas. Cancer Treat Res. 1995;72:349-362.
14. Holst VA, Finkelstein S, Colby TV, Myers JL, Yousem SA. p53 and K-ras mutational genotyping in pulmonary carcinosarcoma, spindle cell carcinoma, and pulmonary blastoma: implications for histogenesis. Am J Surg Pathol. 1997; 21(7):801-811.
15. Takahashi K, Kohno T, Matsumoto S, et al. Clonality and heterogeneity of pulmonary blastoma from the viewpoint of genetic alterations: a case report. Lung Cancer. 2007;57(1):103-108.
16. Dacic S, Finkelstein SD, Sasatomi E, Swalsky PA, Yousem SA. Molecular pathogenesis of pulmonary carcinosarcoma as determined by microdissectionbased allelotyping. Am J Surg Pathol. 2002;26(4):510-516.
17. Nakajima M, Kasai T, Hashimoto H, Iwata Y, Manabe H. Sarcomatoid carcinoma of the lung: a clinicopathologic study of 37 cases. Cancer. 1999; 15;86(4):608-616.
18. Addis BJ, Corrin B. Pulmonary blastoma, carcinosarcoma and spindle-cell carcinoma: an immunohistochemical study of keratin intermediate filaments. J Pathol. 1985;147(4):291-301.
19. Humphrey PA, Scroggs MW, Roggli VL, Shelburne JD. Pulmonary carcinomas with a sarcomatoid element: an immunocytochemical and ultrastructural analysis. Hum Pathol. 1988;19(2):155-165.
20. Ishida T, Tateishi M, Kaneko S, et al. Carcinosarcoma and spindle cell carcinoma of the lung: clinicopathologic and immunohistochemical studies. J Thorac Cardiovasc Surg. 1990;100(6):844-852.
21. Stackhouse EM, Harrison EG Jr, Ellis FH Jr. Primary mixed malignancies of lung: carcinosarcoma and blastoma. J Thorac Cardiovasc Surg. 1969;57(3):385-399.
22. Zimmerman KG, Sobonya RE, Payne CM. Histochemical and ultrastructural features of an unusual pulmonary carcinosarcoma. Hum Pathol. 1981; 12(11):1046-1051.
23. Davis MP, Eagan RT, Weiland LH, Pairolero PC. Carcinosarcoma of the lung: Mayo Clinic experience and response to chemotherapy. Mayo Clin Proc. 1984;59(9):598-603.
24. Koss MN, Hochholzer L, Frommelt RA. Carcinosarcomas of the lung: a clinicopathologic study of 66 patients. Am J Surg Pathol. 1999;23(12):1514-1526.
25. Cosgrove MM, Chandrasoma PT, Martin SE. Diagnosis of pulmonary blastoma by fine-needle aspiration biopsy: cytologic and immunocytochemical findings. Diagn Cytopathol. 1991;7(1):83-87.
26. Koss MN, Hochholzer L, O'Leary T. Pulmonary blastomas. Cancer. 1991; 67(9):2368-2381.
27. Lee KG, Cho NH. Fine-needle aspiration cytology of pulmonary adenocarcinoma of fetal type: report of a case with immunohistochemical and ultrastructural studies. Diagn Cytopathol. 1991;7(4):408-414.
28. Nakatani Y, Dickersin GR, Mark EJ. Pulmonary endodermal tumor resembling fetal lung: a clinicopathologic study of five cases with immunohistochemical and ultrastructural characterization. Hum Pathol. 1990;21(11):1097-1107.
29. Yuki T, Sakuma T, Ohbayashi C, et al. Pleomorphic carcinoma of the lung: a surgical outcome. J Thorac Cardiovasc Surg. 2007;134(2):399-404.
30. Kim TH, Kim SJ, Ryu YH, et al. Pleomorphic carcinoma of lung: comparison of CT features and pathologic findings. Radiology. 2004;232(2): 554-549.
31. Raveglia F, Mezzetti M, Panigalli T, et al. Personal experience in surgical management of pulmonary pleomorphic carcinoma. Ann Thorac Surg. 2004; 78(5):1742-1747.
32. Burnette RE, Ballard BR. Metastatic pleomorphic carcinoma of lung presenting as abdominal pain. J Natl Med Assoc. 2004;96(12):1657-1660.
33. Cabarcos A, Gomez Dorronsoro M, Lobo Beristain JL. Pulmonary carcinosarcoma: a case study and review of the literature. Br J Dis Chest. 1985;79(1):83-94.
34. Nappi O, Swanson PE, Wick MR. Pseudovascular adenoid squamous cell carcinoma of the lung: clinicopathologic study of three cases and comparison with true pleuropulmonary angiosarcoma. Hum Pathol. 1994;25(4):373-378.
35. Hummel P, Cangiarella JF, Cohen JM, Yang G, Waisman J, Chhieng DC. Transthoracic fine-needle aspiration biopsy of pulmonary spindle cell and mesenchymal lesions: a study of 61 cases. Cancer. 2001 25;93(3):187-198.
36. Matsui K, Kitagawa M, Miwa A. Lung carcinoma with spindle cell components: sixteen cases examined by immunohistochemistry. Hum Pathol. 1992;23(11):1289-1297.
37. Ginsberg SS, Buzaid AC, Stern H, Carter D. Giant cell carcinoma of the lung. Cancer. 1992;70(3):606-610.
38. Attanoos RL, Papagiannis A, Suttinont P, Goddard H, Papotti M, Gibbs AR. Pulmonary giant cell carcinoma: pathological entity or morphological phenotype? Histopathology. 1998;32(3):225-231.
39. Boucher LD, Yoneda K. The expression of trophoblastic cell markers by lung carcinomas. Hum Pathol. 1995;26(11):1201-1206.
40. Bocklage TJ, Dail DH, Colby TV. Primary lung tumors infiltrated by osteoclast-like giant cells. Ann Diagn Pathol. 1998;2(4):229-240.
41. Love GL, Daroca PJ Jr. Bronchogenic sarcomatoid squamous cell carcinoma with osteoclast-like giant cells. Hum Pathol. 1983;14(11):1004-1006.
42. Newbould MJ, Benbow EW, Sene A, Young M, Taylor TV. Adenocarcinoma of the pancreas with osteoclast-like giant cells: a case report with immunocytochemistry. Pancreas. 1992;7(5):611-615.
43. Oyasu R, Battifora HA, Buckingham WB, Hidvegi D. Metaplastic squamous cell carcinoma of bronchus simulating giant cell tumor of bone. Cancer. 1977;39(3):1119-1128.
44. Siegel RJ, Bueso-Ramos C, Cohen C, Koss MN. Pulmonary blastoma with germ cell (yolk sac) differentiation: report of two cases. Mod Pathol. 1991;4(5): 566-570.
45. Cohen RE, Weaver MG, Montenegro HD, Abdul-Karim FW. Pulmonary blastoma with malignant melanoma component. Arch Pathol Lab Med. 1990; 114(10):1076-1078.
46. Chejfec G, Cosnow I, Gould NS, Husain AN, Gould VE. Pulmonary blastoma with neuroendocrine differentiation in cell morules resembling neuroepithelial bodies. Histopathology. 1990;17(4):353-358.
47. Travis WD, Colby TV, Corrin B, Shimosato Y, Brambilla E, in collaboration with Sobin LH and pathologists from 14 countries. Histological Typing of Lung and Pleural Tumors. 3rd ed. Berlin, Germany: Springer; 1999.
48. Nakatani Y, Kitamura H, Inayama Y, et al. Pulmonary adenocarcinomas of the fetal lung type: a clinicopathologic study indicating differences in histology, epidemiology, and natural history of low-grade and high-grade forms. Am J Surg Pathol. 1998;22(4):399-411.
49. Müller-Hermelink HK, Kaiserling E. Pulmonary adenocarcinoma of fetal type: alternating differentiation argues in favour of a common endodermal stem cell. Virchows Arch A Pathol Anat Histopathol. 1986;409(2):195-210.
50. Yousem SA, Wick MR, Randhawa P, Manivel JC. Pulmonary blastoma: an immunohistochemical analysis with comparison with fetal lung in its pseudoglandular stage. Am J Clin Pathol. 1990;93(2):167-175.
51. Nakashima M, Inagaki T, Kunimura T, Kushima M, Adachi M, Morohoshi T. Cyopathologic and histologic features of biphasic pulmonary blastoma: a case report. Acta Cytol. 2005;49(1):87-91.
52. Hill DA, Jarzembowski JA, Priest JR, Williams G, Schoettler P, Dehner LP. Type I pleuropulmonary blastoma: pathology and biology study of 51 cases from the international pleuropulmonary blastoma registry. Am J Surg Pathol. 2008; 32(2):282-295.
53. Priest JR, McDermott MB, Bhatia S, Watterson J, Manivel JC, Dehner LP. Pleuropulmonary blastoma: a clinicopathologic study of 50 cases. Cancer. 1997; 80(1):147-161.
54. Priest JR, Hill DA, Williams GM, et al. Type I pleuropulmonary blastoma: a report from the International Pleuropulmonary Blastoma Registry. J Clin Oncol. 2006;24(27):4492-4498.
55. Manivel JC, Priest JR, Watterson J, et al. Pleuropulmonary blastoma: the so-called pulmonary blastoma of childhood. Cancer. 1988;62(8):1516-1526.
56. Hill DA, Ivanovich J, Priest JR, et al. DICER1 mutations in familial pleuropulmonary blastoma. Science. 2009;325(5943):965.
57. Kitazawa R, Kitazawa S, Nishimura Y, Kondo T, Obayashi C. Lung carcinosarcoma with liposarcoma element: autopsy case. Pathol Int. 2006;56(8): 449-452.
58. Finley JL, Silverman JF, Dabbs DJ. Fine-needle aspiration cytology of pulmonary carcinosarcoma with immunocytochemical and ultrastructural observations. Diagn Cytopathol. 1988;4(3):239-243.
59. Ishizuka T, Yoshitake J, Yamada T, et al. Diagnosis of a case of pulmonary carcinosarcoma by detection of rhabdomyosarcoma cells in sputum. Acta Cytol. 1988;32(5):658-662.
60. Tao CW, Chen CH, Chiu MH, Shyu HL, Li WY, Perng RP. Pulmonary carcinosarcoma: diagnostic approach by fine needle aspiration biopsy. Zhonghua Yi Xue Za Zhi (Taipei). 1993;51(3):235-237.
61. Przygodzki RM, Koss MN, Moran CA, et al. Pleomorphic (giant and spindle cell) carcinoma is genetically distinct from adenocarcinoma and squamous cell carcinoma by K-ras-2 and p53 analysis. Am J Clin Pathol. 1996; 106(4):487-492.
62. Pelosi G, Scarpa A, Manzotti M, et al. K-ras gene mutational analysis supports a monoclonal origin of biphasic pleomorphic carcinoma of the lung. Mod Pathol. 2004;17(5):538-546.
63. Gazdar AF. Activating and resistance mutations of EGFR in non-small-cell lung cancer: role in clinical response to EGFR tyrosine kinase inhibitors. Oncogene. 2009;28 (suppl 1):S24-S31.
64. Ushiki A, Koizumi T, Kobayashi N, et al. Genetic heterogeneity of EGFR mutation in pleomorphic carcinoma of the lung: response to gefitinib and clinical outcome. Jpn J Clin Oncol. 2009;39(4):267-270.
65. Blaukovitsch M, Halbwedl I, Kothmaier H, Gogg-Kammerer M, Popper HH. Sarcomatoid carcinomas of the lung-are these histogenetically heterogeneous tumors? Virchows Arch. 2006;449(4):455-461.
66. Pelosi G, Fraggetta F, Nappi O, et al. Pleomorphic carcinomas of the lung show a selective distribution of gene products involved in cell differentiation, cell cycle control, tumor growth, and tumor cell motility: a clinicopathologic and immunohistochemical study of 31 cases. Am J Surg Pathol. 2003;27(9):1203-1215.
67. Yamazaki K. Pulmonary well-differentiated fetal adenocarcinoma expressing lineage-specific transcription factors (TTF-1 and GATA-6) to respiratory epithelial differentiation: an immunohistochemical and ultrastructural study. Virchows Arch. 2003;442(4):393-399.
68. Nakatani Y, Miyagi Y, Takemura T, et al. Aberrant nuclear/cytoplasmic localization and gene mutation of beta-catenin in classic pulmonary blastoma: beta-catenin immunostaining is useful for distinguishing between classic pulmonary blastoma and a blastomatoid variant of carcinosarcoma. Am J Surg Pathol. 2004;28(7):921-927.
69. Sekine S, Shibata T, Matsuno Y, et al. Beta-catenin mutations in pulmonary blastomas: association with morule formation. J Pathol. 2003 ;20(2):214-221.
70. Bodner SM, Koss MN. Mutations in the p53 gene in pulmonary blastomas: immunohistochemical and molecular studies. Hum Pathol. 1996;27(11):1117-1123.
71. Stock N, Chibon F, Binh MB, et al. Adult-type rhabdomyosarcoma: analysis of 57 cases with clinicopathologic description, identification of 3 morphologic patterns and prognosis. Am J Surg Pathol. 2009;33(12):1850-1859.
72. Fletcher CD, Unni KK, Mertens F, eds. Pathology and Genetics of Tumours of Soft Tissue and Bone. Lyon, France: IARC Press; 2002; World Health Organization Classification of Tumours; vol 5.
73. McLendon RE, Roggli VL, Foster WL Jr, Becsey D. Carcinoma of the lung with osseous stromal metaplasia. Arch Pathol Lab Med. 1985;109(11):1051-1053.
74. Boylan AM. Mesothelioma: new concepts in diagnosis and management. Curr Opin Pulm Med. 2000;6(2):157-163.
75. Lin-Chu M, Lee YJ, Ho MY. Malignant mesothelioma in infancy. Arch Pathol Lab Med. 1989;113(4):409-411.
76. Kane MJ, Chahinian AP, Holland JF. Malignant mesothelioma in young adults. Cancer. 1990;65(6):1449-1455.
77. Craighead JE, Gibbs AR, eds. Asbestos and Its Diseases. 1st ed. New York, NY: Oxford University Press; 2008.
78. Churg A, Cagle PT, Roggli VL. Tumors of the Serosal Membranes. Silver Spring, MD: American Registry of Pathology and Armed Forces Institute of Pathology; 2006. AFIP Atlas of Tumor Pathology; 4th series, fascicle 3.
79. Roggli VL, Oury TD, Sporn TA. Pathology of Asbestos-Associated Diseases. 2nd ed. New York, NY: Springer; 2004.
80. Fennell DA, Parmar A, Shamash J, et al. Statistical validation of the EORTC prognostic model for malignant pleural mesothelioma based on three consecutive phase II trials. J Clin Oncol. 2005;23(1):184-189.
81. Gorini G, De GG, Silvestri S, Chellini E, Cupelli V, Seniori CA. Survival of malignant pleural mesothelioma cases in the Tuscan Mesothelioma Register, 1988-2000: a population-based study. Eur J Cancer Prev. 2005;14(3):195-199.
82. Burgers JA, Damhuis RA. Prognostic factors in malignant mesothelioma. Lung Cancer. 2004;45(suppl 1):S49-S54.
83. Klebe S, Brownlee NA, Mahar A, et al. Sarcomatoid mesothelioma: a clinical-pathologic correlation of 326 cases. Mod Pathol. 2010;23(3):470-479.
84. Hammar SP. Controversies and uncertainties concerning the pathologic features and pathologic diagnosis of asbestosis. Semin Diagn Pathol. 1992;9(2): 102-109.
85. Roggli VL, Greenberg SDL, Pratt PC. Pathology of Asbestos-Associated Diseases. Boston, MA: Little, Brown, & Company; 1992.
86. Battifora H, McCaughey WTE. Tumors of the Serosal Membranes. Washington, DC: Armed Forces Institute of Pathology; 1995. Atlas of Tumor Pathology; 3rd series, fascicle 15.
87. Crotty TB, Myers JL, Katzenstein AL, Tazelaar HD, Swensen SJ, Churg A. Localized malignant mesothelioma: a clinicopathologic and flow cytometric study. Am J Surg Pathol. 1994;18(4):357-363.
88. Allen TC, Cagle PT, Churg AM, et al. Localized malignant mesothelioma. Am J Surg Pathol. 2005;29(7):866-873.
89. Klebe S, Mahar A, Henderson DW, Roggli VL. Malignant mesothelioma with heterologous elements: clinicopathological correlation of 27 cases and literature review. Mod Pathol. 2008;21(9):1084-1094.
90. Ordonez NG. Mesothelioma with rhabdoid features: an ultrastructural and immunohistochemical study of 10 cases. Mod Pathol. 2006;19(3):373-383.
91. Galateau-Salle F, Brambilla E, Cagle PT, et al. Pathology of Malignant Mesothelioma. London, United Kingdom: Springer-Verlag; 2006.
92. Mangano WE, Cagle PT, Churg A, Vollmer RT, Roggli VL. The diagnosis of desmoplastic malignant mesothelioma and its distinction from fibrous pleurisy: a histologic and immunohistochemical analysis of 31 cases including p53 immunostaining [comment in Am J Clin Pathol. 1998;110(2):135-136]. Am J Clin Pathol. 1998;110(2):191-199.
93. Roggli VL, Kolbeck J, Sanfilippo F, Shelburne JD. Pathology of human mesothelioma: etiologic and diagnostic considerations. Pathol Annu. 1987; 22 (pt 2):91-131.
94. Roggli VL. Human disease consequences of fiber exposures: a review of human lung pathology and fiber burden data. Environ Health Perspect. 1990;88: 295-303.
95. Churg A, Colby TV, Cagle P, et al. The separation of benign and malignant mesothelial proliferations. Am J Surg Pathol. 2000;24(9):1183-1200.
96. McCaughey WT, Colby TV, Battifora H, et al. Diagnosis of diffuse malignant mesothelioma: experience of a US/Canadian Mesothelioma Panel. Mod Pathol. 1991;4(3):342-353.
97. Machin T, Mashiyama ET, Henderson JA, McCaughey WT. Bony metastases in desmoplastic pleural mesothelioma. Thorax. 1988;43(2):155-156.
98. Begueret H, Galateau-Salle F, Guillou L, et al. Primary intrathoracic synovial sarcoma: a clinicopathologic study of 40 t(X;18)-positive cases from the French Sarcoma Group and the Mesopath Group. Am J Surg Pathol. 2005;29(3): 339-346.
99. Gaertner E, Zeren EH, Fleming MV, Colby TV, Travis WD. Biphasic synovial sarcomas arising in the pleural cavity: a clinicopathologic study of five cases. Am J Surg Pathol. 1996;20(1):36-45.
100. Hartel PH, Fanburg-Smith JC, Frazier AA, et al. Primary pulmonary and mediastinal synovial sarcoma: a clinicopathologic study of 60 cases and comparison with five prior series. Mod Pathol. 2007;20(7):760-769.
101. Zhang PJ, Livolsi VA, Brooks JJ. Malignant epithelioid vascular tumors of the pleura: report of a series and literature review. Hum Pathol. 2000;31(1):29-34.
102. Lin BT, Colby T, Gown AM, et al. Malignant vascular tumors of the serous membranes mimicking mesothelioma: a report of 14 cases. Am J Surg Pathol. 1996;20(12):1431-1439.
103. England DM, Hochholzer L, McCarthy MJ. Localized benign and malignant fibrous tumors of the pleura: a clinicopathologic review of 223 cases[ erratum in Am J Surg Pathol. 1991;15(8):818]. Am J Surg Pathol. 1989;13(8):640-658.
104. Briselli M, Mark EJ, Dickersin GR. Solitary fibrous tumors of the pleura: eight new cases and review of 360 cases in the literature. Cancer. 1981;47(11): 2678-2689.
105. Okike N, Bernatz PE, Woolner LB. Localized mesothelioma of the pleura: benign and malignant variants. J Thorac Cardiovasc Surg. 1978;75(3):363-372.
106. Dalton WT, Zolliker AS, McCaughey WT, Jacques J, Kannerstein M. Localized primary tumors of the pleura: an analysis of 40 cases. Cancer. 1979; 44(4):1465-1475.
107. Al-Izzi M, Thurlow NP, Corrin B. Pleural mesothelioma of connective tissue type, localized fibrous tumour of the pleura, and reactive submesothelial hyperplasia: an immunohistochemical comparison. J Pathol. 1989;158(1):41-44.
108. Said JW, Nash G, Banks-Schlegel S, Sassoon AF, Shintaku IP. Localized fibrous mesothelioma: an immunohistochemical and electron microscopic study. Hum Pathol. 1984;15(5):440-443.
109. Hanau CA, Miettinen M. Solitary fibrous tumor: histological and immunohistochemical spectrum of benign and malignant variants presenting at different sites. Hum Pathol. 1995;26(4):440-449.
110. Strom EH, Skjorten F, Aarseth LB, Haug E. Solitary fibrous tumor of the pleura: an immunohistochemical, electron microscopic and tissue culture study of a tumor producing insulin-like growth factor I in a patient with hypoglycemia [discussion in Pathol Res Pract. 1991;187(1):114-116]. Pathol Res Pract. 1991; 187(1):109-113.
111. Cole FH Jr, Ellis RA, Goodman RC, Weber BC, Courington DP. Benign fibrous pleural tumor with elevation of insulin-like growth factor and hypoglycemia. South Med J. 1990;83(6):690-694.
112. Yousem SA, Flynn SD. Intrapulmonary localized fibrous tumor: intraparenchymal so-called localized fibrous mesothelioma. Am J Clin Pathol. 1988;89(3):365-369.
113. Cardillo G, Carbone L, Carleo F, et al. Solitary fibrous tumors of the pleura: an analysis of 110 patients treated in a single institution. Ann Thorac Surg. 2009;88(5):1632-1637.
114. Harrison-Phipps KM, Nichols FC, Schleck CD, et al. Solitary fibrous tumors of the pleura: results of surgical treatment and long-term prognosis. J Thorac Cardiovasc Surg. 2009;138(1):19-25.
115. Steigen SE, Schaeffer DF, West RB, Nielsen TO. Expression of insulin-like growth factor 2 in mesenchymal neoplasms. Mod Pathol. 2009;22(7):914-921.
116. Schirosi L, Lantuejoul S, Cavazza A, et al. Pleuro-pulmonary solitary fibrous tumors: a clinicopathologic, immunohistochemical, and molecular study of 88 cases confirming the prognostic value of de Perrot staging system and p53 expression, and evaluating the role of c-kit, BRAF, PDGFRs (alpha/beta), c-met, and EGFR. Am J Surg Pathol. 2008;32(11):1627-1642.
117. de Perrot M, Fischer S, Brundler MA, Sekine Y, Keshavjee S. Solitary fibrous tumors of the pleura. Ann Thorac Surg. 2002;74(1):285-293.
118. Mosquera JM, Fletcher CD. Expanding the spectrum of malignant progression in solitary fibrous tumors: a study of 8 cases with a discrete anaplastic component-is this dedifferentiated SFT? Am J Surg Pathol. 2009; 33(9):1314-1321.
119. Flint A, Weiss SW. CD-34 and keratin expression distinguishes solitary fibrous tumor (fibrous mesothelioma) of pleura from desmoplastic mesothelioma. Hum Pathol. 1995;26(4):428-431.
120. Hasegawa T, Matsuno Y, Shimoda T, Hirohashi S, Hirose T, Sano T. Frequent expression of bcl-2 protein in solitary fibrous tumors. Jpn J Clin Oncol. 1998;28(2):86-91.
121. Rodriguez-Gil Y, Gonzalez MA, Carcavilla CB, Santamaria JS. Lines of cell differentiation in solitary fibrous tumor: an ultrastructural and immunohistochemical study of 10 cases. Ultrastruct Pathol. 2009;33(6):274-285.
122. Colby TV, Koss MN, Travis WD. Tumors of the Lower Respiratory Tract. Washington, DC: Armed Forces Institute of Pathology; 1995. Atlas of Tumor Pathology; 3rd series, fascicle 13.